ROBERT A. LEVINE, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
The effects of abnormally high (12 g) and normal (6 g) daily doses of para-aminosalicylic acid (PAS) recrystallized with ascorbic acid (PAS-C) on absorptive function was investigated in seven healthy volunteer subjects. Oral administration of 12 g/day of PAS-C for 4 weeks induced moderate steatorrhea, without diarrhea, in all seven subjects. Six grams per day of PAS-C failed to produqce malabsorption of fats. The drug exhibited no direct toxic effect on intestinal epithelium, as determined by light microscopy. Jejunal mucosal biopsies performed before, during, and after PAS-C administration, at either 6- or 12-g daily doses, showed no alterations in the normal histology. The degree of steatorrhea did not appear to account entirely for the diminished cholesterol concentrations observed during PAS-C therapy. The data indicate that PAS-C, at the 12-g daily dosage, represents another model for investigation of reversible drug-induced malabsorption in man. In contrast, PAS-C in the doses generally recommended did not induce changes in absorptive function.
LEVINE RA. Steatorrhea Induced by Para-aminosalicylic Acid. Ann Intern Med. ;68:1265–1270. doi: 10.7326/0003-4819-68-6-1265
Download citation file:
Published: Ann Intern Med. 1968;68(6):1265-1270.
Celiac Disease and Malabsorption, Gastroenterology/Hepatology.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use